Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofrequency ablation.

Park KW, Shin JH, Han BK, Ko EY, Chung JH.

Ann Surg Oncol. 2011 Sep;18(9):2564-8. doi: 10.1245/s10434-011-1619-1. Epub 2011 Feb 23.

PMID:
21347777
[PubMed - indexed for MEDLINE]
2.

Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma.

Monchik JM, Donatini G, Iannuccilli J, Dupuy DE.

Ann Surg. 2006 Aug;244(2):296-304.

PMID:
16858194
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.

Lyrdal D, Andersson M, Hellström M, Sternal J, Lundstam S.

Acta Radiol. 2010 Sep;51(7):808-18. doi: 10.3109/02841851.2010.489054.

PMID:
20707665
[PubMed - indexed for MEDLINE]
4.

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Mazzaferri EL, Jhiang SM.

Am J Med. 1994 Nov;97(5):418-28. Erratum in: Am J Med 1995 Feb;98(2):215.

PMID:
7977430
[PubMed - indexed for MEDLINE]
5.

[Long term (5 years) outcome of radiofrequency ablation for hepatocellular carcinoma in 256 cases].

Chen MH, Yan K, Yang W, Gao W, Dai Y, Huo L, Zhang H, Huang XF.

Beijing Da Xue Xue Bao. 2005 Dec 18;37(6):671-2. Chinese.

PMID:
16378128
[PubMed - indexed for MEDLINE]
Free Article
6.

Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.

Cappelli C, Pirola I, Braga M, De Martino E, Morassi ML, Gandossi E, Mattanza C, Balzano R, Castellano M, Rosei EA.

Ann Ital Chir. 2006 Mar-Apr;77(2):107-13.

PMID:
17147082
[PubMed - indexed for MEDLINE]
7.

Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation.

Baek JH, Kim YS, Sung JY, Choi H, Lee JH.

AJR Am J Roentgenol. 2011 Aug;197(2):W331-6. doi: 10.2214/AJR.10.5345.

PMID:
21785061
[PubMed - indexed for MEDLINE]
8.

Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors.

Jiao LR, Hansen PD, Havlik R, Mitry RR, Pignatelli M, Habib N.

Am J Surg. 1999 Apr;177(4):303-6.

PMID:
10326848
[PubMed - indexed for MEDLINE]
9.

[Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].

Gemsenjäger E, Heitz PU, Martina B, Schweizer I.

Praxis (Bern 1994). 2000 Nov 2;89(44):1779-97. German.

PMID:
11109916
[PubMed - indexed for MEDLINE]
10.

[Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].

Yang W, Chen MH, Yan K, Gao W, Yin SS, Wang YB, Zhang XP, Xing BC, Huang XF.

Zhonghua Wai Ke Za Zhi. 2005 Aug 1;43(15):980-4. Chinese.

PMID:
16194353
[PubMed - indexed for MEDLINE]
11.

Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group.

Hölzer S, Reiners C, Mann K, Bamberg M, Rothmund M, Dudeck J, Stewart AK, Hundahl SA.

Cancer. 2000 Jul 1;89(1):192-201.

PMID:
10897018
[PubMed - indexed for MEDLINE]
12.

Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival.

Mazzaglia PJ, Berber E, Milas M, Siperstein AE.

Surgery. 2007 Jul;142(1):10-9.

PMID:
17629995
[PubMed - indexed for MEDLINE]
13.

Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome.

Lin JD, Hsueh C, Chao TC.

Thyroid. 2009 Oct;19(10):1053-9. doi: 10.1089/thy.2009.0133.

PMID:
19772423
[PubMed - indexed for MEDLINE]
14.

Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications.

Chen MH, Yang W, Yan K, Gao W, Dai Y, Wang YB, Zhang XP, Yin SS.

World J Gastroenterol. 2005 Oct 28;11(40):6395-401.

PMID:
16419172
[PubMed - indexed for MEDLINE]
Free Article
15.

Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.

Keil S, Bruners P, Schiffl K, Sedlmair M, Mühlenbruch G, Günther RW, Das M, Mahnken AH.

Cardiovasc Intervent Radiol. 2010 Apr;33(2):297-306. doi: 10.1007/s00270-009-9681-9. Epub 2009 Aug 18.

PMID:
19688366
[PubMed - indexed for MEDLINE]
16.

Hepatic radiofrequency under CT-fluoroscopy guidance.

Laganà D, Carrafiello G, Mangini M, Lumia D, Mocciardini L, Chini C, Pinotti G, Cuffari S, Fugazzola C.

Radiol Med. 2008 Feb;113(1):87-100. doi: 10.1007/s11547-008-0224-2. Epub 2008 Feb 25. English, Italian.

PMID:
18338130
[PubMed - indexed for MEDLINE]
17.

Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.

Okuma T, Okamura T, Matsuoka T, Yamamoto A, Oyama Y, Toyoshima M, Koyama K, Inoue K, Nakamura K, Inoue Y.

Ann Nucl Med. 2006 Feb;20(2):115-21.

PMID:
16615420
[PubMed - indexed for MEDLINE]
18.

Long-term survival after radiofrequency ablation of complex unresectable liver tumors.

Amersi FF, McElrath-Garza A, Ahmad A, Zogakis T, Allegra DP, Krasne R, Bilchik AJ.

Arch Surg. 2006 Jun;141(6):581-7; discussion 587-8.

PMID:
16785359
[PubMed - indexed for MEDLINE]
19.

Percutaneous radiofrequency ablation of renal cell carcinoma.

Chiou YY, Hwang JI, Chou YH, Wang JH, Chiang JH, Chang CY.

J Chin Med Assoc. 2005 May;68(5):221-5.

PMID:
15909727
[PubMed - indexed for MEDLINE]
20.

Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.

Choi D, Lim HK, Rhim H, Kim YS, Yoo BC, Paik SW, Joh JW, Park CK.

Ann Surg Oncol. 2007 Aug;14(8):2319-29. Epub 2007 May 24.

PMID:
17522947
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk